Metabolic Bone Disease in Viral Cirrhosis: A Prospective Study
Authors:
Open Access
- 21 April 2013
- journal article
- research article
- Published by Wiley in ISRN Hepatology
- Vol. 2013, 1-6
Abstract
Background/Aim. Metabolic Bone disorders are well-recognized extrahepatic complications of cirrhosis. The aim was to report their prevalence and the associated factors to their development in patients with viral cirrhosis. Patients and Methods. All consecutive patients with viral cirrhosis were prospectively enrolled. Parathyroid hormone, 25-hydroxyvitamin D, liver function, and phosphocalcic tests were measured in all patients. Bone mineral density was measured at the lumbar spine and total hip by dual-energy X-ray absorptiometry. Data were analyzed using SPSS software. Results. Forty-six cirrhotic patients were included with hepatitis C (87%) and hepatitis B (13%). The Child-Pugh score was grade A in 87% of cases and grade B in 13%. Thirty-seven patients had decreased bone mineral density with osteopenia in 24 patients and osteoporosis in 13 patients. Decreased 25-hydroxyvitamin D was found in 95.6% of cases. Bone disorders were significantly more frequent in old patients with low body mass index, long duration of liver disease, and low 25-hydroxyvitamin D level. None of these factors was an independent factor associated with bone disorders. Conclusion. Our study revealed a high prevalence of metabolic bone disorders among viral cirrhotic patients. Consequently, bone mineral density assessment should be performed systematically in all cirrhotic patients.Keywords
This publication has 23 references indexed in Scilit:
- Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective studyClinics and Research in Hepatology and Gastroenterology, 2011
- Évaluation du statut osseux des patients en attente d’une greffe hépatiqueRevue du Rhumatisme, 2011
- Bone mineral density and disorders of mineral metabolism in chronic liver diseaseWorld Journal of Gastroenterology, 2009
- Elevation of Intact Parathyroid Hormone Level Is a Risk Factor for Low Bone Mineral Density in Pretransplant Patients With Liver DiseasesTransplantation Proceedings, 2007
- Bone disorders in chronic liver diseaseHepatology, 2007
- Bone mineral density before and after OLT: Long-term follow-up and predictive factorsLiver Transplantation, 2006
- Bone mineral density among cirrhotic patients awaiting liver transplantationLiver Transplantation, 2004
- AGA technical review on osteoporosis in hepatic disordersGastroenterology, 2003
- American gastroenterological association medical position statement: osteoporosis in hepatic disordersGastroenterology, 2003
- Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosisHepatology, 1998